151 related articles for article (PubMed ID: 27941212)
1. Coexistence of systemic sclerosis and sarcoidosis.
Godziszewska S; Widuchowska M; Kopeć-Mędrek M; Kucharz EJ
Wiad Lek; 2016; 69(4):693-694. PubMed ID: 27941212
[TBL] [Abstract][Full Text] [Related]
2. Sarcoidosis-associated pulmonary hypertension treated with sildenafil - a case report.
Kacprzak A; Szturmowicz M; Burakowska B; Franczuk M; Kober J; Kurzyna M; Wilk M; Szmit S; Torbicki A; Kuś J
Adv Respir Med; 2017; 85(5):258-263. PubMed ID: 29083021
[TBL] [Abstract][Full Text] [Related]
3. [Heart involvement in systemic sclerosis: analysis of four cases].
Wielosz E; Borys O; Błaszczak P; Majdan M
Ann Acad Med Stetin; 2012; 58(1):33-9; discussion 39. PubMed ID: 23547392
[TBL] [Abstract][Full Text] [Related]
4. Systemic sclerosis with sarcoidosis: case report and review of the published work.
Senda S; Igawa K; Nishioka M; Murota H; Katayama I
J Dermatol; 2014 May; 41(5):421-3. PubMed ID: 24617417
[TBL] [Abstract][Full Text] [Related]
5. Interstitial lung disease in systemic sclerosis.
Bussone G; Mouthon L
Autoimmun Rev; 2011 Mar; 10(5):248-55. PubMed ID: 20863911
[TBL] [Abstract][Full Text] [Related]
6. Association of progressive systemic sclerosis with pulmonary sarcoidosis. Just a chance occurrence?
Takahashi T; Munakata M; Homma Y; Kawakami Y
Intern Med; 1997 Jun; 36(6):435-8. PubMed ID: 9213193
[TBL] [Abstract][Full Text] [Related]
7. Paraneoplastic systemic sclerosis: About 3 cases and review of literature.
Monfort JB; Lazareth I; Priollet P
J Mal Vasc; 2016 Dec; 41(6):365-370. PubMed ID: 27751625
[TBL] [Abstract][Full Text] [Related]
8. Clinical and laboratory features of systemic sclerosis complicated with localized scleroderma.
Toki S; Motegi S; Yamada K; Uchiyama A; Kanai S; Yamanaka M; Ishikawa O
J Dermatol; 2015 Mar; 42(3):283-7. PubMed ID: 25582037
[TBL] [Abstract][Full Text] [Related]
9. Preliminary analysis of the very early diagnosis of systemic sclerosis (VEDOSS) EUSTAR multicentre study: evidence for puffy fingers as a pivotal sign for suspicion of systemic sclerosis.
Minier T; Guiducci S; Bellando-Randone S; Bruni C; Lepri G; Czirják L; Distler O; Walker UA; Fransen J; Allanore Y; Denton C; Cutolo M; Tyndall A; Müller-Ladner U; Matucci-Cerinic M; ;
Ann Rheum Dis; 2014 Dec; 73(12):2087-93. PubMed ID: 23940211
[TBL] [Abstract][Full Text] [Related]
10. BAL cytokine profile in different interstitial lung diseases: a focus on systemic sclerosis.
Meloni F; Caporali R; Marone Bianco A; Paschetto E; Morosini M; Fietta AM; Patrizio V; Bobbio-Pallavicini F; Pozzi E; Montecucco C
Sarcoidosis Vasc Diffuse Lung Dis; 2004 Jun; 21(2):111-8. PubMed ID: 15281432
[TBL] [Abstract][Full Text] [Related]
11. Autoantibody profiles in systemic sclerosis: predictive value for clinical evaluation and prognosis.
Hamaguchi Y
J Dermatol; 2010 Jan; 37(1):42-53. PubMed ID: 20175839
[TBL] [Abstract][Full Text] [Related]
12. [Systemic scleroderma and sarcoidosis: 3 new cases].
Bandt MD; Meyer O; Masson C; Peroux-Goumy L; Audran M; Kahn MF
Ann Med Interne (Paris); 1996; 147(8):590-4. PubMed ID: 9137689
[TBL] [Abstract][Full Text] [Related]
13. Preliminary criteria for the very early diagnosis of systemic sclerosis: results of a Delphi Consensus Study from EULAR Scleroderma Trials and Research Group.
Avouac J; Fransen J; Walker UA; Riccieri V; Smith V; Muller C; Miniati I; Tarner IH; Randone SB; Cutolo M; Allanore Y; Distler O; Valentini G; Czirjak L; Müller-Ladner U; Furst DE; Tyndall A; Matucci-Cerinic M;
Ann Rheum Dis; 2011 Mar; 70(3):476-81. PubMed ID: 21081523
[TBL] [Abstract][Full Text] [Related]
14. Graves' disease associated with primary systemic sclerosis.
Wimmersberger Y; Zuercher D
Orbit; 2009; 28(4):262-3. PubMed ID: 19839886
[TBL] [Abstract][Full Text] [Related]
15. Influence of clinical features, serum antinuclear antibodies, and lung function on survival of patients with systemic sclerosis.
Jacobsen S; Ullman S; Shen GQ; Wiik A; Halberg P
J Rheumatol; 2001 Nov; 28(11):2454-9. PubMed ID: 11708418
[TBL] [Abstract][Full Text] [Related]
16. Sarcoidosis in systemic sclerosis: report of 7 cases.
Cox D; Conant E; Earle L; Newman J; Kahaleh B; Jimenez S; Varga J
J Rheumatol; 1995 May; 22(5):881-5. PubMed ID: 8587076
[TBL] [Abstract][Full Text] [Related]
17. Two-year experience with mycophenolate mofetil in patients with scleroderma lung disease: a case series.
Yilmaz N; Can M; Kocakaya D; Karakurt S; Yavuz S
Int J Rheum Dis; 2014 Nov; 17(8):923-8. PubMed ID: 24864029
[TBL] [Abstract][Full Text] [Related]
18. Disease subsets, antinuclear antibody profile, and clinical features in 127 French and 247 US adult patients with systemic sclerosis.
Meyer OC; Fertig N; Lucas M; Somogyi N; Medsger TA
J Rheumatol; 2007 Jan; 34(1):104-9. PubMed ID: 17117486
[TBL] [Abstract][Full Text] [Related]
19. The presence of anti-centromere antibodies may predict progression of estimated pulmonary arterial systolic pressure in systemic sclerosis.
Kampolis C; Plastiras S; Vlachoyiannopoulos P; Moyssakis I; Tzelepis G
Scand J Rheumatol; 2008; 37(4):278-83. PubMed ID: 18612928
[TBL] [Abstract][Full Text] [Related]
20. Pulmonary hypertension: a correct diagnosis for a suitable therapy in scleroderma patients.
Giordano N; Montella A; Corallo C; Ruocco G; Chirico C; Palazzuoli A; Nuti R; Pecetti G
Clin Exp Rheumatol; 2015; 33(4 Suppl 91):S182-9. PubMed ID: 26339897
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
